The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation this year took place on October 15^th, 2020 at National Biotechnology Research Park in Taipei.

Due to the impact of COVID-19 pandemic, this is the first time to hold the online conference with Japan side through Webex.

Since the “Framework of the Cooperation on the Medical Products Regulation” was signed by Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, Taiwan Food and Drug Administration (TFDA) works with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host Annual Joint Conference in alternative turns for eight years.

This year, the representatives from TFDA and MHLW and PMDA shared the latest information regarding the pharmaceutical regulations, as well as other important topics such as regulatory challenge against COVID-19, recent regulatory challenge in medical devices and Quality Management System (QMS) utilization of MOC.

Apart from the TFDA and MHLW and PMDA, around 200 participants from both Taiwan and Japan’s industries joined the conference. The deliverables of this conference include reaching and enhancing the mutual understandings of the regulatory information and the collaborations between regulatory authority and industries.